This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Poxel Sa. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Pascale Fouqueray: Innovator in Diabetes Treatment
Introduction
Pascale Fouqueray is a prominent inventor based in Lyons, France. She has made significant contributions to the field of diabetes treatment, particularly for patients with chronic kidney disease. With a total of 2 patents, her work is paving the way for innovative therapeutic methods.
Latest Patents
Fouqueray's latest patents focus on methods of treating subjects with diabetes who also suffer from chronic kidney disease. The first patent describes a method of treating prediabetes or type 1 or type 2 diabetes mellitus by administering an effective amount of imeglimin to a subject in need. This innovative approach aims to improve the health outcomes of patients facing these dual challenges.
Career Highlights
Pascale Fouqueray is currently associated with Poxel Sa, a company dedicated to developing novel treatments for metabolic diseases. Her expertise and dedication to research have positioned her as a key figure in the advancement of diabetes therapies.
Collaborations
Fouqueray has collaborated with notable professionals in her field, including Bill Symonds and Steve Piscitelli. These partnerships have enhanced her research and contributed to the development of effective treatment methods.
Conclusion
Pascale Fouqueray's innovative work in diabetes treatment exemplifies her commitment to improving patient care. Her contributions are vital in addressing the complexities of diabetes and chronic kidney disease, making her a significant figure in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile